[Anti-allergy therapy in children].
The discovery of the physiopathological mechanisms of asthma and the diseases of allergy has allowed the development of many symptomatic therapeutical perspectives. We review below the mechanisms of actions, routes of administration, secondary effects, dosages and indications for different commercialised anti-allergy medications. A better understanding of the pharmacology of the different medications should produce optimisation of the treatment of the allergic child.
Nicolie
B
B
Laboratoire d'Immuno-Allergologie, CHU, 49033 Angers.
Declerck
A
A
Drouet
M
M
D000280:Administration, Inhalation; D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000627:therapeutic use; D018926:Anti-Allergic Agents / Q000145:classification / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D004205:Cromolyn Sodium / Q000627:therapeutic use; D004837:Epinephrine / Q000627:therapeutic use; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use; D006636:Histamine Release / Q000187:drug effects; D006801:Humans; D007223:Infant; D007665:Ketotifen / Q000627:therapeutic use; D020024:Leukotriene Antagonists; D017835:Nedocromil / Q000627:therapeutic use; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D013806:Theophylline / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D018926:Anti-Allergic Agents; D018680:Cholinergic Antagonists; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists; D020024:Leukotriene Antagonists; D010726:Phosphodiesterase Inhibitors; D017835:Nedocromil; D013806:Theophylline; D004205:Cromolyn Sodium; D007665:Ketotifen; D004837:Epinephrine